These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Intravenous immunoglobulins (IVIg) in the treatment of multiple sclerosis].
    Author: Achiron A, Miron S.
    Journal: Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S41-4. PubMed ID: 10896988.
    Abstract:
    Intravenously administered immunoglobulins (IVIg) have been used for the treatment of various autoimmune diseases. In multiple sclerosis (MS), recent studies point out the beneficial role of this treatment that reduces relapse rate and arrests disease progression in relapsing-remitting patients. In the present article, we summarize and interpret the clinical, immunological, and neuro-radiological data related to IVIg treatment in MS. A synthesis between the information gathered will enable better understanding and treatment of this chronic disease.
    [Abstract] [Full Text] [Related] [New Search]